Table 2.
Correlation between SSTR expression and clinicopathology in colorectal cancer n (%)
| Clinico-pathological factor | n | SSTR1 | SSTR2 | SSTR3 | SSTR4 | SSTR5 | |
| Sex | Male | 73 | 47(64.4) | 26(35.6) | 13(17.8) | 13(17.8) | 28(38.4) |
| Female | 54 | 35(64.8) | 20(37.0) | 11(20.4) | 11(20.4) | 21(38.9) | |
| Age (yr) | < 60 | 66 | 45(68.2) | 20(30.3) | 12(18.2) | 12(18.2) | 24(36.4) |
| ≥ 60 | 61 | 37(60.7) | 26(42.6) | 12(19.7) | 12(19.7) | 25(41.0) | |
| Tumor site | Right colon | 31 | 18(58.1) | 11(35.5) | 7(22.6) | 6(19.4) | 11(35.5) |
| Left colon | 27 | 17(63.0) | 12(44.4) | 5(18.5) | 6(22.2) | 13(48.1) | |
| Rectum | 69 | 47(68.1) | 23(33.3) | 12(17.4) | 12(17.4) | 25(36.2) | |
| Macroscopic type | Elevated | 40 | 27(67.5) | 17(42.5) | 10(25.0) | 9(22.5) | 17(42.5) |
| Ulcerative | 59 | 37(62.7) | 13(22.0)a | 8(13.6) | 8(13.6) | 21(35.6) | |
| Infiltrative | 28 | 18(64.3) | 16(57.1) | 6(21.4) | 7(25.0) | 11(39.3) | |
| Differentiation | Moderate to well | 102 | 70(68.6) | 43(42.2)a | 22(21.6) | 24(23.5)a | 46(45.1)a |
| Poor | 25 | 12(48.0) | 3(12.0) | 2(8.0) | 0(0.0) | 3(12.0) | |
| Tumor depth | Muscularis | 24 | 14(58.3) | 11(45.8) | 5(20.8) | 3(12.5) | 9(37.5) |
| Serosa | 103 | 68(66.0) | 35(34.0) | 19(18.4) | 21(20.4) | 40(38.8) | |
| Lymph node metastasis | (+) | 72 | 52(72.2)a | 24(33.3) | 12(16.7) | 15(20.8) | 26(36.1) |
| (-) | 55 | 30(54.5) | 22(40.0) | 12(21.8) | 9(16.4) | 23(41.8) | |
| Distant metastasis | (+) | 20 | 15(75.0) | 6(30.0) | 3(15.0) | 2(10.0) | 7(35.0) |
| (-) | 107 | 67(62.6) | 40(37.4) | 21(19.6) | 22(20.6) | 42(39.3) | |
| Dukes’ stage | A | 13 | 7(53.8) | 5(38.5) | 4(30.8) | 2(15.4) | 6(46.2) |
| B | 40 | 22(55.0) | 16(40.0) | 8(20.0) | 7(17.5) | 16(40.0) | |
| C | 54 | 38(70.4) | 19(35.2) | 9(16.7) | 13(24.1) | 20(37.0) | |
aP < 0.05.